Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2007 4
2008 7
2009 2
2010 2
2011 1
2012 6
2013 3
2014 5
2015 4
2016 6
2017 5
2018 12
2019 8
2020 8
2021 9
2022 12
2023 13
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of drug-susceptible and multidrug-resistant tuberculosis (MDR-TB) in the Central Region of Somalia: A 3-year retrospective study.
Mohamed MA, Ali OA, Osman AM, Abatcha MG, Ahmed AA, Ali AM, Dirie AA, de Oliveira CJB, Osman AY, Wang SH, Vieira RFC. Mohamed MA, et al. Among authors: wang sh. PLOS Glob Public Health. 2023 Sep 7;3(9):e0002319. doi: 10.1371/journal.pgph.0002319. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37676848 Free PMC article.
Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
Nabity SA, Marks SM, Goswami ND, Smith SR, Timme E, Price SF, Gross L, Self JL, Toren KG, Narita M, Wegener DH, Wang SH; National Tuberculosis Controllers Association/CDC TB-COVID-19 Collaboration1. Nabity SA, et al. Among authors: wang sh. Emerg Infect Dis. 2023 Oct;29(10):2016-2023. doi: 10.3201/eid2910.230286. Epub 2023 Aug 30. Emerg Infect Dis. 2023. PMID: 37647628 Free PMC article.
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Haley CA, Schechter MC, Ashkin D, Peloquin CA, Peter Cegielski J, Andrino BB, Burgos M, Caloia LA, Chen L, Colon-Semidey A, DeSilva MB, Dhanireddy S, Dorman SE, Dworkin FF, Hammond-Epstein H, Easton AV, Gaensbauer JT, Ghassemieh B, Gomez ME, Horne D, Jasuja S, Jones BA, Kaplan LJ, Khan AE, Kracen E, Labuda S, Landers KM, Lardizabal AA, Lasley MT, Letzer DM, Lopes VK, Lubelchek RJ, Patricia Macias C, Mihalyov A, Misch EA, Murray JA, Narita M, Nilsen DM, Ninneman MJ, Ogawa L, Oladele A, Overman M, Ray SM, Ritger KA, Rowlinson MC, Sabuwala N, Schiller TM, Schwartz LE, Spitters C, Thomson DB, Tresgallo RR, Valois P, Goswami ND; BPaL Implementation Group. Haley CA, et al. Clin Infect Dis. 2023 Oct 5;77(7):1053-1062. doi: 10.1093/cid/ciad312. Clin Infect Dis. 2023. PMID: 37249079 Free PMC article.
Screening for Latent Tuberculosis Infection in Adults: An Evidence Review for the U.S. Preventive Services Task Force [Internet].
Jonas DE, Riley S, Lee L, Coffey C, Wang SH, Asher GN, Berry A, Williams N, Balio C, Voisin CE, Kahwati L. Jonas DE, et al. Among authors: wang sh. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 May. Report No.: 22-05298-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 May. Report No.: 22-05298-EF-1. PMID: 37192326 Free Books & Documents. Review.
100 results